SCHEMBL23728175

SCHEMBL23728175

Oc1ccc(/C=C\C/C=C\c2ccc(O)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 6/20 0.59
MAOB P27338 3/20 0.54
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 3/20 0.54
MAPT P10636 3/20 0.54
CYP2C9 P11712 3/20 0.54
CA12 O43570 3/20 0.54
CA1 P00915 3/20 0.54
CA2 P00918 3/20 0.54
CA3 P07451 3/20 0.54
CA4 P22748 3/20 0.54
CA6 P23280 3/20 0.54
CA5A P35218 3/20 0.54
CA7 P43166 3/20 0.54
CA9 Q16790 3/20 0.54
CA14 Q9ULX7 3/20 0.54
CA5B Q9Y2D0 3/20 0.54
AKR1B1 P15121 3/20 0.54
TYR P14679 3/20 0.54
CA13 Q8N1Q1 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28837412 0.91 PTGS1 (0.57) APPMAOBCA12CA1CA2
SCHEMBL29711827 0.87 APP (0.48) APPMAOBKDM4EALDH1A1MAPT
SCHEMBL9247768 0.85 APP (0.50) APPMAOBKDM4EALDH1A1MAPT
SCHEMBL9247763 0.85 APP (0.50) APPMAOBKDM4EALDH1A1MAPT
SCHEMBL221967 0.84 ALDH1A1 (0.59) APPMAOBKDM4EALDH1A1MAPT
SCHEMBL31289417 0.84 APP (0.54) APPMAOBKDM4EALDH1A1MAPT
SCHEMBL221968 0.84 ALDH1A1 (0.59) APPMAOBKDM4EALDH1A1MAPT
SCHEMBL107687 0.82 APP (0.52) APPMAOBKDM4EALDH1A1MAPT
SCHEMBL10421204 0.82 APP (0.54) APPMAOBKDM4EALDH1A1MAPT
SCHEMBL6397551 0.82 APP (0.52) APPMAOBKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118948982-A Compositions comprising alpinia and other plant extracts for improving joint health and treating arthritis 尤尼根公司 2024-11-15 CN disclosed
CN-115515614-B Compositions comprising alpinia and other plant extracts for improving joint health and treating arthritis 尤尼根公司 2024-07-23 CN disclosed
CN-115515614-A Compositions comprising extracts of alpinia and other plants for improving joint health and treating arthritis 尤尼根公司 2022-12-23 CN disclosed
EP-4100034-A1 COMPOSITIONS COMPRISING EXTRACTS OF APLINIA AND OTHER PLANTS FOR IMPROVING JOINT HEALTH AND TREATING ARTHRITIS Unigen, Inc. (US) 2022-12-14 EP disclosed
US-20220000964-A1 Compositions and Methods for Regulating Homeostasis of Chondrocytes, Extracellular Matrix, Articular Cartilage, and Phenotype of Arthritis UNIGEN, INC. (US) 2022-01-06 US disclosed
WO-2021159042-A1 COMPOSITIONS COMPRISING EXTRACTS OF APLINIA AND OTHER PLANTS FOR IMPROVING JOINT HEALTH AND TREATING ARTHRITIS UNIGEN, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220000964-A1 Compositions and Methods for Regulating Homeostasis of Chondrocytes, Extracellular Matrix, Articular Cartilage, and Phenotype of Arthritis COL2A1, COL1A1, CKAP4 APP 3886/4885MAOB 3518/4885KDM4E 726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.